Redhawk Wealth Advisors Inc. Has $308,000 Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Redhawk Wealth Advisors Inc. lessened its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 50.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 4,361 shares of the company’s stock after selling 4,414 shares during the period. Redhawk Wealth Advisors Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $308,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in IHE. Mercer Global Advisors Inc. ADV lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 7.4% during the second quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock worth $254,000 after buying an additional 266 shares during the last quarter. Janney Montgomery Scott LLC grew its position in iShares U.S. Pharmaceuticals ETF by 3.0% in the 1st quarter. Janney Montgomery Scott LLC now owns 12,489 shares of the company’s stock worth $848,000 after purchasing an additional 358 shares during the last quarter. Cultivar Capital Inc. bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth about $25,000. Rothschild Investment LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the second quarter valued at about $26,000. Finally, Concourse Financial Group Securities Inc. grew its position in iShares U.S. Pharmaceuticals ETF by 331.0% during the first quarter. Concourse Financial Group Securities Inc. now owns 543 shares of the company’s stock worth $37,000 after buying an additional 417 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Up 0.1 %

Shares of IHE opened at $71.08 on Tuesday. The stock’s 50-day moving average price is $70.78 and its 200 day moving average price is $67.81. iShares U.S. Pharmaceuticals ETF has a 12-month low of $55.36 and a 12-month high of $72.94. The firm has a market capitalization of $717.91 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.